Skip to main content
. 2020 Aug 18;9(8):2669. doi: 10.3390/jcm9082669

Table 1.

Main clinical and biological features of a multicenter sample of 444 polypathological patients recruited for sarcopenia and frailty assessment.

Clinical Features Mean (SD)/Median -IQR-/N (%)
Number of defining categories (major diseases) per patient 2.5 (0.5)
Prevalence of defining categories (major diseases)
Heart diseases 374 (84.6%)
Kidney/autoimmune diseases 202 (45.7%)
Lung diseases 183 (41.4%)
Neurological diseases 133 (30.1%)
Peripheral arterial disease/diabetes with neuropathy 80 (18.1%)
Neoplasia/chronic anemia 70 (15.8%)
Degenerative osteoarticular disease 43 (9.7%)
Liver disease 28 (6.3%)
Number of other comorbidities per patient 5.9 (2.3)
Most frequent comorbidities
Hypertension 380 (86%)
Dyslipemia 232 (52.5%)
Diabetes with no visceral involvement 216 (49%)
Atrial fibrillation 178 (40%)
Obesity 159 (36%)
Anxiety and depressive disorders 74 (17%)
Benign prostate hyperplasia 64 (14.5%)
Frequent symptoms
Fatigue 304 (70%)
Anorexia 212 (48%)
Insomnia 194 (44%)
Chronic pain 178 (40%)
Cough 158 (36%)
Patients with basal III-IV class of NYHA//III–IV class of mMRC 128 (29%)
PROFUND index 6 -6-
Basal Barthel’s Index 66 (30)
BMI (Kg/m2) 30 (6.6%)
Main biological parameters
Hemoglobin (d/dL) 11.3 (2)
Creatinin (mg/dL) 1.26 (1)
Albumin (g/dL) 3.2 (0.9)
Cholesterol (mg/dL) 151 (42)
Triglicerydes (mg/dL) 116 -80-
Vitamin D (ng/mL) 11 -17-
Leucocytes (n°/µL) 8000 -4000-
Lymphocytes (n°/µL) 1200 -400-

SD: standard deviation; IQR: interquartile range; NYHA: New York Heart Association; mMRC: Medical Research Council. BMI: body mass index.